Enhancing the Role of Commune Health Workers in HIV and Drug Control: A Randomized Controlled Trial

October 11, 2018 updated by: Li Li, PhD, University of California, Los Angeles
This proposed study is an initiative for HIV prevention and care that integrates intervention efforts at multiple strata: Community Health Workers (CHWs), Injecting Drug Users (IDUs), and their Family Members (FMs). The proposed study will demonstrate the process of development, implementation, and evaluation of an intervention for CHWs, IDUs, and their FMs. One aim is to increase the CHWs' capacities to effectively interact with IDUs and FMs for HIV and drug use prevention and treatment. Using a combination of participatory action research and a randomized controlled trial design, this study has the potential to maximize PEPFAR impact in Vietnam and other PEPFAR-funded countries by identifying a sustainable mix of interventions and their implementation in different settings. The findings may benefit not only Vietnam but also a global audience by investigating enhanced methods for controlling the HIV epidemic.

Study Overview

Status

Completed

Conditions

Detailed Description

Vietnam is currently facing an HIV epidemic that had affected approximately 280,000 people by the end of 2009. Injecting Drug Use (IDU) is principal driver of the HIV epidemic, contributing to between 32 % and 58 % of all HIV cases in various provinces. However, it has proven difficult to address the needs of IDUs, a high-risk group, given the prevalence of stigmatization and drug use in Vietnamese society. In addition, Vietnamese people are highly family oriented and most young IDUs have daily family contact of live in their parents' homes. Thus the burden on the family is substantial, and even greater if the IDU is HIV+.

The study will be implemented in two provinces in Vietnam: Phu Tho and Vinh Phuc. A randomized controlled trial will be conducted to evaluate the impact of the intervention in 60 commune health centers. From each center we will recruit 5 Community Health Workers (CHWs), 15 Injecting Drug Users (IDUs), and 10 Family Members (FMs) (totaling 300 CHWs, 900 IDUs, and 600 FMs). The outcomes will be evaluated at 3-, 6-, 9-, and 12- month follow-up assessments. The specific aims of the study are as follows:

  1. To develop and implement an integrated intervention, CHW CARE, for CHWs, IDUs, and their FMS in Vietnam
  2. To evaluate the feasibility and operational procedures of the intervention with an implementation pilot, including process evalution and monitoring, and participants feedback.
  3. To assess the impact of the intervention by comparing outcome measures of CHWs, IDUs, and FMs in the intervention group to those in the control group.
  4. To explore the relationships between the intervention outcomes of CHWs, IDUs, and FMs.

Study Type

Interventional

Enrollment (Actual)

1800

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Phú Thọ, Vietnam
        • Phú Thọ commune health centers
      • Vĩnh Phúc, Vietnam
        • Vĩnh Phúc commune health centers

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

Injecting Drug Users:

  • Age 18 or over
  • Having a history of drug use
  • Currently residing in the selected commune, and have no plan to move to other communes in the following year
  • Voluntary informed consent

Family members of Injecting Drug Users:

  • Age 18 or over
  • Immediate or extended family member of the Injecting Drug User.
  • Previous knowledge of the drug use of the IDU.
  • Voluntary informed consent
  • Currently residing in the selected commune, and have no plan to move to other communes in the following year

Community Health Workers:

  • Age 18 or over
  • Doctor, nurse, or other care provider working at the selected commune health centers
  • Informed consent

Exclusion Criteria:

Injecting Drug Users:

  • Those who have psychosis or neurological damage, or cannot understand the study purposes as judged by the interviewer in consultation with a clinic supervisor, will be excluded
  • Does not meet other inclusion criteria

Family members of Injecting Drug Users:

  • Those who have psychosis or neurological damage, or cannot understand the study purposes as judged by the interviewer in consultation with a clinic supervisor, will be excluded
  • Does not meet other inclusion criteria

Community Health Workers:

  • Inability to give informed consent
  • Does not meet other inclusion criteria

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
NO_INTERVENTION: Control
Community Health Workers (CHWs) in the control group will be invited to one group lecture didactically reviewing medical ethics, and the attending CHWs will be requested to pay a home visit to participating IDUs and FMs after the lecture.
EXPERIMENTAL: Intervention

Intervention for CHWs: 3 sessions will cover the understanding stigma and its impact, self-protection and universal precaution adherence, effective communication with patients and family members, and motivational enhancement for behavioral change.

Intervention for IDUs: CHWs who participate in the intervention will be required to conduct 3 individual sessions with participating IDUs covering the following topics: physical health, risk reduction behaviors, mental health, and community integration.

Intervention for FMs: CHWs who participate in the intervention will be required to conduct 2 group sessions with participating FMs covering the following topics: healthy family routine, coping with caregiver burdens, enhance family relationships, support positive behavior change.

Intervention for CHWs: 3 sessions will cover the understanding stigma and its impact, self-protection and universal precaution adherence, effective communication with patients and family members, and motivational enhancement for behavioral change.

Intervention for IDUs: CHWs who participate in the intervention will be required to conduct 3 individual sessions with participating IDUs covering the following topics: physical health, risk reduction behaviors, mental health, and community integration.

Intervention for FMs: CHWs who participate in the intervention will be required to conduct 2 group sessions with participating FMs covering the following topics: healthy family routine, coping with caregiver burdens, enhance family relationships, support positive behavior change.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Community Health Worker (CHW) Interaction with patients
Time Frame: Changes from baseline to 3-, 6-, 9- and 12- month follow-up
Provider-Client interaction scale will be used.
Changes from baseline to 3-, 6-, 9- and 12- month follow-up
Injecting Drug User (IDU) drug use
Time Frame: baseline, 3-, 6-, 9- and 12- month follow-up
Urine test results
baseline, 3-, 6-, 9- and 12- month follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Community Health Worker (CHW) job safety, support, and satisfaction
Time Frame: Changes from baseline to 3-, 6-, 9-, and 12- month follow-up
This will be assessed by perceived risk at work and institutional support. Additionally by job satisfaction using a 29-item scale.
Changes from baseline to 3-, 6-, 9-, and 12- month follow-up
Community Health Worker (CHW) knowledge and adherence to universal precautions
Time Frame: Changes from baseline to 3-, 6-, 9-, and 12- month follow-up
This will be assessed with the universal precautions knowledge scale.
Changes from baseline to 3-, 6-, 9-, and 12- month follow-up
Injecting Drug User (IDU) family and social support
Time Frame: Changes from baseline to 3-, 6-, 9- and 12- month follow-up
This is measured by two instruments. Social Support Questionnaire (Short; SSQ6) is a 6-item assessment to measure satisfaction of social support. Number of social support providers is captured up to 9 people in various support dimensions (Sarason et al., 1983). Medical Outcomes Study- Social Support Scale (MOS-SS) is a 20-item scale that measures the strength of perceived social support available. The scale consists of five dimensions: emotional support, informational support, tangible support, positive social interaction, and affection
Changes from baseline to 3-, 6-, 9- and 12- month follow-up
Family Member (FM) social support
Time Frame: Changes from baseline to 3-, 6-, 9-, and 12- month follow-up
This is measured by two instruments. Social Support Questionnaire (Short; SSQ6) is a 6-item assessment to measure satisfaction of social support. Number of social support providers is captured up to 9 people in various support dimensions (Sarason et al., 1983). Medical Outcomes Study- Social Support Scale (MOS-SS) is a 20-item scale that measures the strength of perceived social support available. The scale consists of five dimensions: emotional support, informational support, tangible support, positive social interaction, and affection.
Changes from baseline to 3-, 6-, 9-, and 12- month follow-up
Community Health Worker (CHW) general prejudicial attitude
Time Frame: Changes from baseline to 3-, 6-, 9- and 12- month follow-up
A scale will be used
Changes from baseline to 3-, 6-, 9- and 12- month follow-up
Family Member (FM) Caregiver burden/coping
Time Frame: Changes from baseline to 3-,6-,9-, and 12-month follow-up
Caregiver burden and coping scales will be used
Changes from baseline to 3-,6-,9-, and 12-month follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

July 1, 2014

Primary Completion (ACTUAL)

May 1, 2018

Study Completion (ACTUAL)

May 1, 2018

Study Registration Dates

First Submitted

May 1, 2014

First Submitted That Met QC Criteria

May 5, 2014

First Posted (ESTIMATE)

May 6, 2014

Study Record Updates

Last Update Posted (ACTUAL)

October 12, 2018

Last Update Submitted That Met QC Criteria

October 11, 2018

Last Verified

October 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • R01DA033609-01 (NIH)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Drug Dependence

Clinical Trials on Intervention to Address Drug Use and HIV in Vietnam

3
Subscribe